|
|
|
Volumn 93 Suppl 1, Issue , 2005, Pages
|
|
Fulvestrant ('Faslodex'): extending the reach of endocrine therapy?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
DRUG DERIVATIVE;
ESTRADIOL;
FULVESTRANT;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
BREAST TUMOR;
DRUG RESISTANCE;
EDITORIAL;
FEMALE;
HUMAN;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
ESTRADIOL;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
HUMANS;
|
|
EID: 32944482678
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
